Cooperative Agreement U01CA294811
Award Date
8/12/24
Completion Date
7/31/29
Dollars Obligated
$654K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Cooperative Agreement
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
This federal Project Grant award of $1,861,650.00, provided by the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research program), supports the development and national testing of a culturally tailored mHealth intervention called MASP+ that aims to address smoking cessation, mental health, and HIV disease management among Black adults with HIV. The 5-year project will involve formative research to refine the MASP+...
This $316,873 Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and pilot testing of a smartphone app version of the evidence-based "Libre del Cigarrillo" smoking cessation intervention for Spanish-speaking individuals. The key goals are to: 1) adapt the existing validated printed smoking cessation intervention for Spanish-speakers into a smartphone app format, and 2) conduct a...
This federal Project Grant award for $625,201 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) supports a randomized factorial trial to evaluate the effectiveness of combining varenicline with nicotine lozenges and a smartphone medication adherence intervention to promote smoking cessation. The study aims to enroll 496 adult smokers and assess 7-day point prevalence abstinence at 26 weeks and medication adherence over the 13-week...
This $1,226,040 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to develop and test a culturally-tailored suite of smoking cessation resources for American Indian (AI) persons. The key products/services to be delivered include: Co-creating a culturally-aligned website, "Smokefree.gov for Natives", to serve as the landing page for AI-specific cessation content and resources. Conducting a randomized...
This federal Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $728,006 to the University of Chicago to conduct a 2x2 factorial randomized controlled trial. The study aims to optimize treatment of co-occurring smoking and unhealthy alcohol use among people with HIV in Nairobi, Kenya. The key products and services to be delivered include: Evaluating the efficacy of an intensive behavioral counseling...
The National Cancer Institute (NCI) awarded a 5-year, $757,913 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Fred Hutchinson Cancer Center in Seattle, Washington. The grant will fund a randomized controlled trial to determine whether providing a smoking cessation smartphone app (iCanQuit) in combination with free nicotine replacement therapy (NRT) is more effective and cost-effective for increasing biochemically verified 30-day smoking abstinence among...
This Cooperative Agreement awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $639,964 to the University of Wisconsin - Madison to evaluate implementation strategies to promote smoking treatment and cancer prevention for Salvation Army clients. The project aims to refine and evaluate two promising implementation strategies to help Salvation Army staff connect their clients who smoke with the Wisconsin Tobacco Quit Line: 1) a low-intensity,...
This federal Project Grant award for $399,891, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, funds a feasibility study to evaluate the use of the SensewHy, Inc. "SmonkeMon" wearable device for remotely monitoring smoking behavior and triggers among cancer survivors. The key products and services to be delivered under this Phase 1 SBIR project include: 1) assessing the feasibility of the SmonkeMon device for...
This $707,367 federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, is funding the development and evaluation of a mobile health (mHealth) intervention called GEMS for people who are ambivalent about quitting smoking. The GEMS app uses a series of self-guided exercises to help engage these individuals, build their motivation and confidence to quit, and connect them to evidence-based quit smoking treatments like...
This $643,363 Cooperative Agreement, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will support a hybrid type III effectiveness-implementation trial to test best practices for deploying a "screen and treat" approach to cervical cancer screening using self-collected HPV DNA testing within HIV care and treatment facilities in Mozambique. The primary outcome is to increase the number of women screened and treated for...